Abstract
Hypoxia promotes vascularization by stabilization and activation of the hypoxia inducible factor 1 alpha (HIF-1 alpha), which constitutes a target for angiogenic gene therapy. However, gene therapy is hampered by low gene delivery efficiency and nonspecific side effects. Here, we developed a gene transfer technique based on magnetic targeting of magnetic nanopartidelentivirus (MNP-LV) complexes allowing site -directed gene delivery to individual wounds in the dorsal skin of mice. Using this technique, we were able to control HIF-1 alpha dependent wound healing angiogenesis in vivo via site-specific modulation of the tyrosine phosphatase activity of SHP-2. We thus uncover a novel physiological role of SHP-2 in protecting HIF-1 a from proteasomal degradation via a Src kinase dependent mechanism, resulting in HIF-1 a DNA-binding and transcriptional activity in vitro and in vivo. Excitingly, using targeting of MNP-LV complexes, we achieved simultaneous expression of constitutively active as well as inactive SHP-2 mutant proteins in separate wounds in vivo and hereby specifically and locally controlled HIF-la activity as well as the angiogenic wound healing response in vivo. Therefore, magnetically targeted lentiviral induced modulation of SHP-2 activity may be an attractive approach for controlling patho-physiological conditions relying on hypoxic vessel growth at specific sites.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
ISSN: | 1525-0016 |
Sprache: | Englisch |
Dokumenten ID: | 50342 |
Datum der Veröffentlichung auf Open Access LMU: | 14. Jun. 2018, 09:43 |
Letzte Änderungen: | 04. Nov. 2020, 13:28 |